IL-12 and type I IFN response of neonatal myeloid DC to human CMV infection

European Journal of Immunology

Volumn 39, Issue 10, 2009, Pages 2789-2799

  Renneson, Joelle ^a   Dutta, Binita ^a   Goriely, Stanislas ^a   Danis, Bénédicte ^a   Lecomte, Sandra ^a   Laes, Jean François ^b   Tabi, Zsuzsanna ^c   Goldman, Michel ^a   Marchant, Arnaud ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b DNAVision SA   (Belgium)

^c VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

Cytokines; DC; IFN; Infectious diseases; Neonate immunity

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 12;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; DOWN REGULATION; GENE CONTROL; HUMAN; HUMAN CELL; IN VITRO STUDY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; UPREGULATION; VIRUS IMMUNITY;

ADULT; CHEMOKINE CXCL9; CHEMOKINES; CYTOKINES; CYTOMEGALOVIRUS; DENDRITIC CELLS; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HLA ANTIGENS; HUMANS; INFANT, NEWBORN; INTERFERON TYPE I; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERONS; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; UP-REGULATION; VIRAL PROTEINS;

EID: 70350536363     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939414     Document Type: Article

References (58)

1. Wilson, C. B. and Lewis, D. B., Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection. Rev. Infect. Dis. 1990. 12:S410-S420.
2. Marodi, L., Innate cellular immune responses in newborns. Clin. Immunol. 2006. 118: 137-144.
3. Adkins, B., Leclerc, C. and Marshall-Clarke, S., Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 2004. 4: 553-564.
4. Stagno, S., Pass, R. F., Cloud, G., Britt,W. J., Henderson, R. E.,Walton, P. D., Veren, D. A. et al., Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. J. Am. Med. Assoc. 1986. 256: 1904-1908.
5. Gandhi, M. K. and Khanna, R., Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect. Dis. 2004. 4: 725-738.
6. Kenneson, A. and Cannon, M. J., Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev. Med. Virol. 2007. 17: 253-276.
7. Marchant, A., Appay, V., Van Der, S. M., Dulphy, N., Liesnard, C., Kidd, M., Kaye, S. et al., Mature CD8(1) T lymphocyte response to viral infection during fetal life. J. Clin. Invest. 2003. 111: 1747-1755.
8. Tu,W., Chen, S., Sharp, M., Dekker, C., Manganello, A. M., Tongson, E. C., Maecker, H. T. et al., Persistent and selective deficiency of CD4+T cell immunity to cytomegalovirus in immunocompetent young children. J. Immunol. 2004. 172: 3260-3267. (Pubitemid 38263718)
9. Miles, D. J., Sande, M., Kaye, S., Crozier, S., Ojuola, O., Palmero, M. S., Sanneh, M. et al., CD4(+) T cell responses to cytomegalovirus in early life: a prospective birth cohort study. J. Infect. Dis. 2008. 197: 658-662.
10. Pass, R. F., Stagno, S., Britt, W. J. and Alford, C. A., Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J. Infect. Dis. 1983. 148: 953-961.
11. Pollara, G., Kwan, A., Newton, P. J., Handley, M. E., Chain, B. M. and Katz, D. R., Dendritic cells in viral pathogenesis: protective or defective? Int. J. Exp. Pathol. 2005. 86: 187-204.
12. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A. and Alber, G., Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp. Med. 1996. 184: 747-752. (Pubitemid 26324129)
13. Watford, W. T., Moriguchi, M., Morinobu, A. and O'Shea, J. J., The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 2003. 14: 361-368. (Pubitemid 37099449)
14. Trinchieri, G., Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003. 3: 133-146.
15. Grandvaux, N., tenOever, B. R., Servant, M. J. and Hiscott, J., The interferon antiviral response: from viral invasion to evasion. Curr. Opin. Infect. Dis. 2002. 15: 259-267.
16. Boxel-Dezaire, A. H., Rani, M. R. and Stark, G. R., Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 2006. 25: 361-372.
17. Meager, A., Visvalingam, K., Dilger, P., Bryan, D. and Wadhwa, M., Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 2005. 31: 109-118. (Pubitemid 40910226)
18. Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A. et al., IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 2003. 4: 69-77.
19. Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R. et al., IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 2003. 4: 63-68.
20. Aksoy, E., Albarani, V., Nguyen, M., Laes, J. F., Ruelle, J. L., De Wit, D., Willems, F. et al., Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. Blood 2007. 109: 2887-2893. (Pubitemid 46482085)
21. Goriely, S., Vincart, B., Stordeur, P., Vekemans, J., Willems, F., Goldman, M. and De Wit, D., Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol. 2001. 166: 2141-2146.
22. Velilla, P. A., Rugeles, M. T. and Chougnet, C. A., Defective antigen-presenting cell function in human neonates. Clin. Immunol. 2006. 121: 251-259.
23. Moutaftsi, M., Mehl, A. M., Borysiewicz, L. K. and Tabi, Z., Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 2002. 99: 2913-2921. (Pubitemid 34525381)
24. Riegler, S., Hebart, H., Einsele, H., Brossart, P., Jahn, G. and Sinzger, C., Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J. Gen. Virol. 2000. 81: 393-399.
25. Cao,W. and Liu, Y. J., Innate immune functions of plasmacytoid dendritic cells. Curr. Opin. Immunol. 2007. 19: 24-30.
26. Diebold, S. S., Montoya, M., Unger, H., Alexopoulou, L., Roy, P., Haswell, L. E., Al Shamkhani, A. et al., Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003. 424: 324-328. (Pubitemid 36899375)
27. Osterlund, P., Veckman, V., Siren, J., Klucher, K. M., Hiscott, J., Matikainen, S. and Julkunen, I., Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J. Virol. 2005. 79: 9608-9617. (Pubitemid 41022304)
28. Libraty, D. H., Pichyangkul, S., Ajariyakhajorn, C., Endy, T.P. and Ennis, F. A., Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J. Virol. 2001. 75: 3501-3508. (Pubitemid 32246359)
29. Kvale, E. O., Dalgaard, J., Lund-Johansen, F., Rollag, H., Farkas, L., Midtvedt, K., Jahnsen, F. L. et al., CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection. Blood 2006. 107: 2022-2029. (Pubitemid 43289386)
30. De Wit, D., Olislagers, V., Goriely, S., Vermeulen, F., Wagner, H., Goldman, M. and Willems, F., Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 2004. 103: 1030-1032. (Pubitemid 38129567)
31. Gold, M. C., Donnelly, E., Cook, M. S., Leclair, C. M. and Lewinsohn, D. A., Purified neonatal plasmacytoid dendritic cells overcome intrinsic maturation defect with TLR agonist stimulation. Pediatr. Res. 2006. 60: 34-37.
32. Danis, B., George, T. C., Goriely, S., Dutta, B., Renneson, J., Gatto, L., Fitzgerald-Bocarsly, P. et al., Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells. Eur. J. Immunol. 2008. 38: 507-517.
33. Pichlmair, A., Schulz, O., Tan, C. P., Naslund, T. I., Liljestrom, P., Weber, F. and Reis e Sousa, C., RIG-I-mediated antiviral responses to single-stranded RNA bearing 50-phosphates. Science 2006. 314: 997-1001.
34. Coccia, E. M., Severa, M., Giacomini, E., Monneron, D., Remoli, M. E., Julkunen, I., Cella, M. et al., Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 2004. 34: 796-805.
35. Boehme, K. W., Guerrero, M. and Compton, T., Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J. Immunol. 2006. 177: 7094-7102. (Pubitemid 44715077)
36. Kawai, T. and Akira, S., Innate immune recognition of viral infection. Nat. Immunol. 2006. 7: 131-137.
37. Honda, K., Takaoka, A. and Taniguchi, T., Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006. 25: 349-360. (Pubitemid 44354220)
38. Sugiyama, S., Nakabayashi, K., Baba, I., Sasazuki, T. and Shirasawa, S., Role of epiregulin in peptidoglycan-induced proinflammatory cytokine production by antigen presenting cells. Biochem. Biophys. Res. Commun. 2005. 337: 271-274.
39. Liao, B., Hu, Y., Herrick, D.J. and Brewer, G., The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J. Biol. Chem. 2005. 280: 18517-18524.
40. Hansenne, I., Renard-Charlet, C., Greimers, R. and Geenen, V., Dendritic cell differentiation and immune tolerance to insulin-related peptides in Igf2-deficient mice. J. Immunol. 2006. 176: 4651-4657.
41. Browne, E. P., Wing, B., Coleman, D. and Shenk, T., Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J Virol. 2001. 75: 12319-12330. (Pubitemid 33115904)
42. Simmen, K. A., Singh, J., Luukkonen, B. G., Lopper, M., Bittner, A., Miller, N. E., Jackson, M. R. et al., Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc. Natl. Acad. Sci. USA 2001. 98: 7140-7145.
43. Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I. and Lanzavecchia, A., Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 1999. 189: 821-829.
44. Carter, L. L. and Murphy, K. M., Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon gamma production from CD4(+) versus CD8(+) T cells. J. Exp. Med. 1999. 189: 1355-1360.
45. Way, S. S., Havenar-Daughton, C., Kolumam, G. A., Orgun, N. N. and Murali-Krishna, K., IL-12 and Type-I IFN synergize for IFN-gamma production by CD4 T cells, whereas neither are required for IFN-gamma production by CD8 T cells after Listeria monocytogenes infection. J. Immunol. 2007. 178: 4498-4505. (Pubitemid 46492402)
46. Marchant, A. and Goldman, M., T cell-mediated immune responses in human newborns: ready to learn? Clin. Exp. Immunol. 2005. 141: 10-18.
47. Biron, C. A., Interferons alpha and beta as immune regulators--a new look. Immunity 2001. 14: 661-664.
48. Stetson, D. B. and Medzhitov, R., Type I interferons in host defense. Immunity 2006. 25: 373-381.
49. Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J. and Murali-Krishna, K., Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp. Med. 2005. 202: 637-650. (Pubitemid 41248415)
50. Cousens, L. P., Peterson, R., Hsu, S., Dorner, A., Altman, J. D., Ahmed, R. and Biron, C. A., Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J. Exp. Med. 1999. 189: 1315-1328.
51. Sinzger, C., Schmidt, K., Knapp, J., Kahl,M., Beck, R.,Waldman, J., Hebart, H. et al., Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J. Gen. Virol. 1999. 80: 2867-2877.
52. Bolstad, B. M., Irizarry, R. A., Astrand, M. and Speed, T. P., A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003. 19: 185-193. (Pubitemid 36181903)
53. Irizarry, R. A., Hobbs, B., Collin, F., Beazer-Barclay, Y. D., Antonellis, K. J., Scherf, U. and Speed, T. P., Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003. 4: 249-264.
54. Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B. et al., Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004. 5: R80.
55. Tusher, V. G., Tibshirani, R. and Chu, G., Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 2001. 98: 5116-5121.
56. Benjamini, Y. and Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 1995. 57: 289-300.
57. Smyth, G. K., Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004. 3: Article 3.
58. Yang, Y. H., Dudoit, S., Luu, P., Lin, D.M., Peng, V., Ngai, J. and Speed, T. P., Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 2002. 30: e15.